HAEMONETICS CORP
Acción · US4050241003 · HAE · 881782 (XNYS)
71,65 USD
09.06.2025 20:00
Cotizaciones actuales de HAEMONETICS CORP
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NYSE |
HAE
|
USD
|
09.06.2025 20:00
|
71,65 USD
| 70,46 USD
+1,69 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 1,59 % | 5,07 % | 4,29 % | -13,61 % | -16,31 % | -27,38 % |
Profil de l'entreprise pour HAEMONETICS CORP Action
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Données de l'entreprise
Nom HAEMONETICS CORP
Société Haemonetics Corporation
Symbole HAE
Site web
https://www.haemonetics.com
Marché d'origine
NYSE

WKN 881782
ISIN US4050241003
Type de titre Action
Secteur Healthcare
Industrie Medical - Instruments & Supplies
PDG Mr. Christopher A. Simon
Capitalisation boursière 3 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 3,7 T
Adresse 125 Summer Street, 02110 Boston
Date d'introduction en bourse 1991-05-10
Fractionnements d'actions
Date | Fractionnement |
---|---|
03.12.2012 | 2:1 |
11.01.1993 | 2:1 |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | HAZ.F |
NYSE | HAE |
Autres actions
Les investisseurs qui détiennent HAEMONETICS CORP ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.